Over time, metformins ability to treat insulin resistance without weight gain or increased risk of hypoglycemia was recognized, and it was introduced to the US in 1995
Hydroxytyrosol Extreme is formulated to have the highest potency available standardized to 25%, compared to others which are standardized to 6% or less, to promote longevity and decrease age-related loss of function through improved heart function, normal immune response, and healthy levels of inflammation
A., Dunn, J., Haupt, A., Milicevic, Z., & Coskun, T
It is not approved for human or veterinary use by the FDA or any other regulatory agency